Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349528 · ClinicalTrials.gov registry record · Phase 2
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
A Phase 2 study, sponsored by Sheppard Pratt Health System.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT03349528 is a Phase 2 study that is active but no longer recruiting, run by Sheppard Pratt Health System. The registered enrollment target is 80 participants.
The verdict
NCT03349528, a Phase 2 study, is active but no longer recruiting, sponsored by Sheppard Pratt Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.
Interventions
- BIOLOGICAL Inert Compound
- BIOLOGICAL Probiotic Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03349528
The ClinicalTrials.gov registry entry for NCT03349528 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sheppard Pratt Health System, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Inert Compound is the first listed.
NCT03349528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03349528 about?
NCT03349528 is a clinical study titled "Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression". The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.
What is the current status of trial NCT03349528?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2018-12-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT03349528?
The interventions under investigation include: Inert Compound (BIOLOGICAL), Probiotic Supplement (BIOLOGICAL).
Who is sponsoring clinical trial NCT03349528?
This trial is sponsored by Sheppard Pratt Health System, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.